Lisa Hayes
VP, Investor Relations and Corporate Communications

Lisa Hayes joined Cyteir in February of 2021 as VP, Investor Relations and Corporate Communications. Lisa brings more than 20 years of experience in investor relations, communications and competitive intelligence in the biopharmaceutical industry. Prior to joining Cyteir, Lisa was head of investor relations and corporate communications at Tmunity Therapeutics and ProQR Therapeutics. She spent more than a decade at Celgene where she held roles in competitive intelligence, marketing and investor relations. Prior to Celgene, Lisa held roles in strategic competitive intelligence at Ortho-Biotech (now Janssen Pharmaceuticals), Aventis (now Sanofi) and McKinsey & Company. Lisa earned her MBA from St. Joseph’s University, a MS in chemical physics from New York University and a BS in chemistry from Seton Hall University.